Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Jiangxi Multiple Myeloma Active Trials & Centers
As of 2026-10-21, there are 30 active clinical trials for multiple myeloma hosted across 9 tertiary medical centers in Jiangxi (including The First Affiliated Hospital of Nanchang University, Jiangxi Cancer Hospital, The First Affiliated Hospital of Gannan Medical University, etc.).
Participating Medical Centers (9)
Active Studies in Jiangxi (30)
Population synthesized by CMDNShowing 0 published English records of 30 registry trials.
All 30 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.